|
Tuesday & Wednesday, June 30 - July 1, 2009
You are invited to participate in the second annual workshop on
“Pregnancy Registry Methods - The Challenges of Pregnancy Drug Safety Studies in the Global Environment”
Pregnancy registries
- are a key component of many Risk Management Plans for pharmaceuticals
- are increasing in number worldwide
- yet present many methodological challenges that are common across various registry designs
Join us to hear experts from a variety of pregnancy registries on selected topics, and submit an abstract for the poster presentation/discussion session.
Workshop Only Registration Fees: (Download Registration Form PDF )
Advance Registration: $675*
On-Site Registration: $700*
Joint TS/OTIS Pregnancy Registry Program
|
Tuesday, July 1, 2009 |
| |
|
4:45 PM - 7:45 PM |
Joint TS/OTIS Pregnancy Registry Workshop Part 1 |
| |
Chairpersons: Christina D. Chambers, University of California, San Diego and Lewis B. Holmes, MassGeneral Hospital For Children |
| |
|
| 4:45 PM – 4:50 PM |
Introduction
Speaker: Lewis B. Holmes, MassGeneral Hospital for Children |
| |
|
| 4:50 PM – 5:05 PM |
Variability across Current Pregnancy Registry Designs: Impact on Interpretation of Results
Speaker: Laura McKain, Kendle International |
| |
|
| 5:05 PM – 5:25 PM |
Sources of Bias in Pregnancy Registries
Speaker: Gideon Koren, The Hospital For Sick Children |
| |
|
| 5:25 PM – 5:45 PM |
Retrospective Versus Prospective Registry Designs: A Place for Both
Speakers: Vince Armenti, National Transplant Registry and the Neoral Pregnancy Registry for Psoriasis and Rheumatoid Arthritis |
| |
|
| 5:45 PM – 6:00 PM |
Panel Discussion |
| |
|
| 6:00 PM - 7:45 PM |
Poster Session (Located in the Exhibit Hall) |
| |
|
Wednesday, July 1, 2009 |
| |
|
| 8:00 AM – 12:15 PM |
Joint TS/OTIS Pregnancy Registry Workshop Part 2 |
| |
Chairpersons: Karen Feibus, U.S. Food and Drug Administration and Diego Wyszynski, Amgen |
| |
|
| 8:00 AM – 8:20 AM |
Pregnancy Exposure Registries in Resource Limited Settings in Africa, Asia and Latin America
Speaker: Melba Gomes, World Health Organization |
| |
|
| 8:20 AM – 8:40 AM |
When Is It Time to Close a Pregnancy Registry
Speaker: Jan Cragan, Centers for Disease Control and Prevention |
| |
|
| 8:40 AM – 9:00 AM |
Signal Detection Rules across Pregnancy Registries: Do They Make Sense?
Speaker: Deborah Covington, Kendle International |
| |
|
| 9:00 AM – 9:20 AM |
The Decision-Making Process during Pregnancy: Impact on Pregnancy Registries
Speakers: Sara Eggers, Decision Partners |
| |
|
| 9:20 AM – 11:15 AM |
Platform Session |
| |
|
9:20 AM – 9:35 AM |
Pregnancy Outcomes from the Pregnancy Registry for Gardasil® (Human Papillomavirus types 6/11/16/18 vaccine) |
|
Dana A, Buchanan KM, Goss MA, Seminack MM, Shields K, Haupt RM. Merck Research Laboratories, West Point, PA, United States. |
| |
|
9:35 AM – 9:50 AM |
Using Pregnancy Registries to Estimate Spontaneous Abortion Rates |
|
Roberts S1, Albano J2, McKain L2, Covington D2. 1University of North Carolina, Wilmington, NC, United States, 2Kendle International, Inc., Wilmington, NC, United States. |
| |
|
9:50 AM – 10:05 AM |
Evaluation of Pregnancy Exposure Registries for Pharmaceuticals |
|
Cummins SK. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs Immediate Office, Pediatric and Maternal Health Staff, Silver Spring, MD, United States. |
| |
|
10:05 AM – 10:20 AM |
National Transplantation Pregnancy Registry (NTPR): Outcomes of Pregnancies in Female Transplant Recipients |
|
Carll M1, Coscia LA1, Constantinescu S2, Armenti VT1. 1Thomas Jefferson University, Philadelphia, PA, United States, 2Temple University, Philadelphia, PA, United States. |
| |
|
10:20 AM – 10:30 AM |
Discussion |
| |
|
| 10:30 AM – 11:00 AM |
Warkany Tea/Break |
| |
|
| 11: 00 AM – 11:15 AM |
Comparative Safety of Some Anticonvulsant Polytherapies during Pregnancy
Holmes LB1, Smith CR1, Shen A1, Mittendorf R3, Hernandez-Diaz S2. 1MassGeneral Hospital for Children, Boston, MA, United States, 2Harvard School of Public Health, Boston, MA, United States, 3Loyola University Medical Center, Maywood, IL, United States. |
| |
|
| 11:15 AM – 11:35 AM |
Steps toward a National Call Center for Pregnancy Registries
Speakers: Karen Feibus, U.S. Food and Drug Administration and Diego Wyszynski, Amgen |
| |
|
| 11:35 AM – 11:55 PM |
How to Design a Pregnancy Registry for a Suspected Human Teratogen
Speaker: Sonja Rasmussen, Centers for Disease Control and Prevention |
| |
|
| 11:55 PM – 12:15 PM |
Panel Discussion |
| |
|
|